EP3984093 - DRUG DELIVERY DEVICE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 18.03.2022 Database last updated on 17.07.2024 | |
Former | The international publication has been made Status updated on 18.12.2020 | ||
Former | unknown Status updated on 17.06.2020 | Most recent event Tooltip | 13.05.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states SANOFI 54 rue La Boétie 75008 Paris / FR | [2022/16] | Inventor(s) | 01 /
JUGL, Michael c/o Sanofi-Aventis Deutschland GmbH 65926 Frankfurt am Main / DE | 02 /
BLANCKE, Stefan c/o Sanofi-Aventis Deutschland GmbH 65926 Frankfurt am Main / DE | 03 /
TEUCHER, Axel c/o Sanofi-Aventis Deutschland GmbH 65926 Frankfurt am Main / DE | 04 /
BIGALKE, Jörg c/o Sanofi-Aventis Deutschland GmbH 65926 Frankfurt am Main / DE | 05 /
TOPOREK, Maurice c/o Sanofi-Aventis Deutschland GmbH 65926 Frankfurt am Main / DE | [2022/16] | Representative(s) | Derry, Paul Stefan Venner Shipley LLP 200 Aldersgate London EC1A 4HD / GB | [2022/16] | Application number, filing date | 20731495.6 | 12.06.2020 | [2022/16] | WO2020EP66373 | Priority number, date | EP20190305751 | 13.06.2019 Original published format: EP 19305751 | [2022/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020249775 | Date: | 17.12.2020 | Language: | EN | [2020/51] | Type: | A1 Application with search report | No.: | EP3984093 | Date: | 20.04.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.12.2020 takes the place of the publication of the European patent application. | [2022/16] | Search report(s) | International search report - published on: | EP | 17.12.2020 | Classification | IPC: | H01M12/06, A61M5/24, H01M2/10 | [2022/16] | CPC: |
H01M12/06 (EP);
A61M5/178 (CN);
A61M5/3157 (US);
A61M5/1452 (CN);
A61M5/16804 (CN);
A61M5/16877 (CN);
A61M5/20 (CN,US);
A61M5/2455 (US);
A61M5/31 (CN);
A61M5/315 (CN);
A61M5/31501 (CN);
A61M5/31511 (CN,US);
A61M5/31525 (CN);
A61M5/31535 (CN);
A61M5/31536 (CN);
A61M5/31541 (CN);
A61M5/31546 (CN);
A61M5/31548 (CN);
A61M5/31566 (CN);
A61M5/31568 (US);
A61M5/31578 (CN);
A61M5/3158 (US);
H01M50/216 (EP);
A61M2005/2006 (CN);
A61M2005/2026 (CN);
A61M2005/2485 (EP);
A61M2205/121 (EP);
A61M2205/123 (EP);
A61M2205/18 (US);
A61M2205/3569 (US);
A61M2205/502 (US);
A61M2205/52 (EP);
A61M2205/581 (CN,US);
A61M2205/582 (CN,US);
A61M2205/583 (CN,US);
A61M2205/8206 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/16] | Title | German: | ARZNEIMITTELABGABEVORRICHTUNG | [2022/16] | English: | DRUG DELIVERY DEVICE | [2022/16] | French: | DISPOSITIF D'ADMINISTRATION DE MÉDICAMENT | [2022/16] | Entry into regional phase | 13.01.2022 | National basic fee paid | 13.01.2022 | Designation fee(s) paid | 13.01.2022 | Examination fee paid | Examination procedure | 13.01.2022 | Examination requested [2022/16] | 13.01.2022 | Date on which the examining division has become responsible | 12.07.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 20.03.2022 | Renewal fee patent year 03 | 31.03.2023 | Renewal fee patent year 04 | 13.05.2024 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XA]US2008294108 (BRIONES VICTOR [US], et al) [X] 1,3,4,24-26 * paragraphs [0041] , [0042] , [0043] , [0054] , [0070] , [0103]; figures 1,18 * [A] 5-18; | [X]WO2009013735 (MEDINGO LTD [IL], et al) [X] 1-4,24-26 * paragraphs [0046] , [0077] , [0078] , [0098] , [0099]; figures 3a-5d *; | [X]WO2018078178 (NOVO NORDISK AS [DK]) [X] 19-26 * page 3, line 23 - page 4, line 15 ** page 15, lines 22-26 * | by applicant | WO2016193122 |